Reduction in movement-evoked pain and fatigue during initial 30-minute transcutaneous electrical nerve stimulation treatment predicts transcutaneous electrical nerve stimulation responders in women with fibromyalgia. 2021

Carol G T Vance, and M Bridget Zimmerman, and Dana L Dailey, and Barbara A Rakel, and Katharine M Geasland, and Ruth L Chimenti, and Jon M Williams, and Meenakshi Golchha, and Leslie J Crofford, and Kathleen A Sluka
Department of Physical Therapy and Rehabilitation Science, University of Iowa, Iowa City, IA, United States.

We previously showed that 1 month of transcutaneous electrical nerve stimulation (TENS) reduces movement-evoked pain and fatigue in women with fibromyalgia (FM). Using data from this study (Fibromyalgia Activity Study with TENS [FAST]), we performed a responder analysis to identify predictors of clinical improvement in pain and fatigue with TENS, validated these models using receiver operator characteristic, and determined number needed to treat and number needed to harm. Participants were randomly assigned to active-TENS (2-125 Hz; highest-tolerable intensity), placebo-TENS, or no-TENS for 1 month. At the end of the randomized phase, placebo-TENS and no-TENS groups received active-TENS for 1 month. The predictor model was developed using data from the randomized phase for the active-TENS group (n = 103) and validated using data from placebo-TENS and no-TENS groups after active-TENS for 1 month (n = 155). Participant characteristics, initial response to TENS for pain and fatigue, sleep, psychological factors, and function were screened for association with changes in pain or fatigue using a logistic regression model. Predictors of clinical improvement in pain were initial response to pain and widespread pain index (area under the curve was 0.80; 95% confidence interval: 0.73-0.87). Predictors of clinical improvement in fatigue were marital status, sleep impairment, and initial response to TENS (area under the curve was 0.67; 95% confidence interval: 0.58-0.75). Number needed to treat for pain and fatigue ranged between 3.3 and 5.3. Number needed to harm ranged from 20 to 100 for minor TENS-related adverse events. The response to an initial 30-minute TENS treatment predicts who responds to longer-term TENS use in women with FM, making this a clinically useful procedure. Number needed to treat and number needed to harm suggest that TENS is effective and safe for managing pain and fatigue in FM.

UI MeSH Term Description Entries
D010146 Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. Suffering, Physical,Ache,Pain, Burning,Pain, Crushing,Pain, Migratory,Pain, Radiating,Pain, Splitting,Aches,Burning Pain,Burning Pains,Crushing Pain,Crushing Pains,Migratory Pain,Migratory Pains,Pains, Burning,Pains, Crushing,Pains, Migratory,Pains, Radiating,Pains, Splitting,Physical Suffering,Physical Sufferings,Radiating Pain,Radiating Pains,Splitting Pain,Splitting Pains,Sufferings, Physical
D010147 Pain Measurement Scales, questionnaires, tests, and other methods used to assess pain severity and duration in patients or experimental animals to aid in diagnosis, therapy, and physiological studies. Analgesia Tests,Analogue Pain Scale,Formalin Test,McGill Pain Questionnaire,Nociception Tests,Pain Assessment,Pain Intensity,Pain Severity,Tourniquet Pain Test,Visual Analogue Pain Scale,Analog Pain Scale,Assessment, Pain,McGill Pain Scale,Visual Analog Pain Scale,Analgesia Test,Analog Pain Scales,Analogue Pain Scales,Formalin Tests,Intensity, Pain,Measurement, Pain,Nociception Test,Pain Assessments,Pain Intensities,Pain Measurements,Pain Questionnaire, McGill,Pain Scale, Analog,Pain Scale, Analogue,Pain Scale, McGill,Pain Severities,Pain Test, Tourniquet,Questionnaire, McGill Pain,Scale, Analog Pain,Scale, Analogue Pain,Scale, McGill Pain,Severity, Pain,Test, Analgesia,Test, Formalin,Test, Nociception,Test, Tourniquet Pain,Tests, Nociception,Tourniquet Pain Tests
D004561 Transcutaneous Electric Nerve Stimulation The use of specifically placed small electrodes to deliver electrical impulses across the SKIN to relieve PAIN. It is used less frequently to produce ANESTHESIA. Analgesic Cutaneous Electrostimulation,Electric Stimulation, Transcutaneous,Electroanalgesia,Percutaneous Electric Nerve Stimulation,TENS,Transdermal Electrostimulation,Electrical Stimulation, Transcutaneous,Percutaneous Electrical Nerve Stimulation,Percutaneous Electrical Neuromodulation,Percutaneous Neuromodulation Therapy,Transcutaneous Electrical Nerve Stimulation,Transcutaneous Nerve Stimulation,Cutaneous Electrostimulation, Analgesic,Electrical Neuromodulation, Percutaneous,Electrical Neuromodulations, Percutaneous,Electroanalgesias,Electrostimulation, Analgesic Cutaneous,Electrostimulation, Transdermal,Nerve Stimulation, Transcutaneous,Neuromodulation Therapy, Percutaneous,Neuromodulation, Percutaneous Electrical,Neuromodulations, Percutaneous Electrical,Percutaneous Electrical Neuromodulations,Percutaneous Neuromodulation Therapies,Stimulation, Transcutaneous Electric,Stimulation, Transcutaneous Nerve,Therapy, Percutaneous Neuromodulation,Transcutaneous Electric Stimulation,Transcutaneous Electrical Stimulation
D005221 Fatigue The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli. Lassitude
D005260 Female Females
D005356 Fibromyalgia A common nonarticular rheumatic syndrome characterized by myalgia and multiple points of focal muscle tenderness to palpation (trigger points). Muscle pain is typically aggravated by inactivity or exposure to cold. This condition is often associated with general symptoms, such as sleep disturbances, fatigue, stiffness, HEADACHES, and occasionally DEPRESSION. There is significant overlap between fibromyalgia and the chronic fatigue syndrome (FATIGUE SYNDROME, CHRONIC). Fibromyalgia may arise as a primary or secondary disease process. It is most frequent in females aged 20 to 50 years. (From Adams et al., Principles of Neurology, 6th ed, p1494-95) Diffuse Myofascial Pain Syndrome,Fibrositis,Rheumatism, Muscular,Fibromyalgia, Primary,Fibromyalgia, Secondary,Fibromyalgia-Fibromyositis Syndrome,Fibromyositis-Fibromyalgia Syndrome,Myofascial Pain Syndrome, Diffuse,Fibromyalgia Fibromyositis Syndrome,Fibromyalgia-Fibromyositis Syndromes,Fibromyalgias,Fibromyalgias, Primary,Fibromyalgias, Secondary,Fibromyositis Fibromyalgia Syndrome,Fibromyositis-Fibromyalgia Syndromes,Fibrositides,Muscular Rheumatism,Primary Fibromyalgia,Primary Fibromyalgias,Secondary Fibromyalgia,Secondary Fibromyalgias,Syndrome, Fibromyalgia-Fibromyositis,Syndrome, Fibromyositis-Fibromyalgia,Syndromes, Fibromyalgia-Fibromyositis,Syndromes, Fibromyositis-Fibromyalgia
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Carol G T Vance, and M Bridget Zimmerman, and Dana L Dailey, and Barbara A Rakel, and Katharine M Geasland, and Ruth L Chimenti, and Jon M Williams, and Meenakshi Golchha, and Leslie J Crofford, and Kathleen A Sluka
November 2016, Journal of physical therapy science,
Carol G T Vance, and M Bridget Zimmerman, and Dana L Dailey, and Barbara A Rakel, and Katharine M Geasland, and Ruth L Chimenti, and Jon M Williams, and Meenakshi Golchha, and Leslie J Crofford, and Kathleen A Sluka
November 2013, Pain,
Carol G T Vance, and M Bridget Zimmerman, and Dana L Dailey, and Barbara A Rakel, and Katharine M Geasland, and Ruth L Chimenti, and Jon M Williams, and Meenakshi Golchha, and Leslie J Crofford, and Kathleen A Sluka
January 1984, The Journal of foot surgery,
Carol G T Vance, and M Bridget Zimmerman, and Dana L Dailey, and Barbara A Rakel, and Katharine M Geasland, and Ruth L Chimenti, and Jon M Williams, and Meenakshi Golchha, and Leslie J Crofford, and Kathleen A Sluka
October 2003, The journal of pain,
Carol G T Vance, and M Bridget Zimmerman, and Dana L Dailey, and Barbara A Rakel, and Katharine M Geasland, and Ruth L Chimenti, and Jon M Williams, and Meenakshi Golchha, and Leslie J Crofford, and Kathleen A Sluka
June 2009, Journal of rehabilitation medicine,
Carol G T Vance, and M Bridget Zimmerman, and Dana L Dailey, and Barbara A Rakel, and Katharine M Geasland, and Ruth L Chimenti, and Jon M Williams, and Meenakshi Golchha, and Leslie J Crofford, and Kathleen A Sluka
April 2014, Rheumatology international,
Carol G T Vance, and M Bridget Zimmerman, and Dana L Dailey, and Barbara A Rakel, and Katharine M Geasland, and Ruth L Chimenti, and Jon M Williams, and Meenakshi Golchha, and Leslie J Crofford, and Kathleen A Sluka
May 2020, Acta odontologica Scandinavica,
Carol G T Vance, and M Bridget Zimmerman, and Dana L Dailey, and Barbara A Rakel, and Katharine M Geasland, and Ruth L Chimenti, and Jon M Williams, and Meenakshi Golchha, and Leslie J Crofford, and Kathleen A Sluka
January 2014, Srpski arhiv za celokupno lekarstvo,
Carol G T Vance, and M Bridget Zimmerman, and Dana L Dailey, and Barbara A Rakel, and Katharine M Geasland, and Ruth L Chimenti, and Jon M Williams, and Meenakshi Golchha, and Leslie J Crofford, and Kathleen A Sluka
October 2017, The Cochrane database of systematic reviews,
Carol G T Vance, and M Bridget Zimmerman, and Dana L Dailey, and Barbara A Rakel, and Katharine M Geasland, and Ruth L Chimenti, and Jon M Williams, and Meenakshi Golchha, and Leslie J Crofford, and Kathleen A Sluka
January 1985, Archivio stomatologico,
Copied contents to your clipboard!